MIGUEL
ARRABAL MARTÍN
PROFESOR TITULAR DE UNIVERSIDAD
University of Milan
Milán, ItaliaPublicaciones en colaboración con investigadores/as de University of Milan (4)
2024
-
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies
OncoImmunology, Vol. 13, Núm. 1
-
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆
Annals of Oncology, Vol. 35, Núm. 2, pp. 159-182
-
Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network—Breast dataset (SCAN-B)
ESMO Open, Vol. 9, Núm. 3